v3.25.1
Schedule of Significant Expense Categories (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total revenues $ 93,864 $ 7,617,174
Other research and development programs 1,061,571 2,818,926
Stock-based compensation 71,002 99,306
Total segment operating income (loss) (2,090,184) 3,222,529
Other income (loss) 225,511 291,292
Net income (loss) (1,864,873) 3,513,621
Reportable Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenues 93,864 7,617,174
Non-program expenses [1] 731,043 1,203,846
Personnel costs 1,084,765 1,036,597
Stock-based compensation 71,002 99,306
Total segment operating income (loss) (2,090,184) 3,222,529
Other income (loss) [2] 225,311 291,092
Net income (loss) (1,864,873) 3,513,621
Reportable Segment [Member] | L P C N 1154 [Member]    
Segment Reporting Information [Line Items]    
Other research and development programs [3] 6,692 1,652,486
Reportable Segment [Member] | Other Research And Development Programs [Member]    
Segment Reporting Information [Line Items]    
Other research and development programs [3] $ 290,546 $ 402,410
[1] Includes general and administrative expenses, information technology, infrastructure, facilities, and intellectual property, and legal and professional fees.
[2] Includes interest income and loss on warrant liability.
[3] Includes external research and development expenses.